Natural killer cells and human immunodeficiency virus

Natural Killer Cells

Volumn , Issue , 2010, Pages 481-497

  Mavilio, Domenico ^a   Hosmalin, Anne ^b   Scott Algara, Daniel ^c  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b INSTITUT COCHIN   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884737617     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-370454-2.00036-3     Document Type: Chapter

References (112)

1. Adam C., King S., Allgeier T., Braumuller H., Luking C., Mysliwietz J., Kriegeskorte A., Busch D.H., Rocken M., Mocikat R. DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction. Blood 2005, 106:338-344.
2. Ahmad A., Menezes J. Antibody-dependent cellular cytotoxicity in HIV infections. FASEB J 1996, 10:258-266.
3. Ahmad R., Sindhu S.T., Tran P., Toma E., Morisset R., Menezes J., Ahmad A. Modulation of expression of the MHC class I-binding natural killer cell receptors, and NK activity in relation to viral load in HIV-infected/AIDS patients. J Med Virol 2001, 65:431-440.
4. Alimonti J.B., Ball T.B., Fowke K.R. Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J Gen Virol 2003, 84:1649-1661.
5. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., Berger E.A. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996, 272:1955-1958.
6. Alter G., Martin M.P., Teigen N., Carr W.H., Suscovich T.J., Schneidewind A., Streeck H., Waring M., Meier A., Brander C., Lifson J.D., Allen T.M., Carrington M., Altfeld M. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 2007, 204:3027-3036.
7. Alter G., Teigen N., Davis B.T., Addo M.M., Suscovich T.J., Waring M.T., Streeck H., Johnston M.N., Staller K.D., Zaman M.T., Yu X.G., Lichterfeld M., Basgoz N., Rosenberg E.S., Altfeld M. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 2005, 106:3366-3369.
8. Arthos J., Cicala C., Martinelli E., Macleod K., Van Ryk D., Wei D., Xiao Z., Veenstra T.D., Conrad T.P., Lempicki R.A., McLaughlin S., Pascuccio M., Gopaul R., McNally J., Cruz C.C., Censoplano N., Chung E., Reitano K.N., Kottilil S., Goode D.J., Fauci A.S. HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol 2008, 9:301-309.
9. Azzoni L., Chehimi J., Zhou L., Foulkes A.S., June R., Maino V.C., Landay A., Rinaldo C., Jacobson L.P., Montaner L.J. Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells. AIDS 2007, 21:293-305.
10. Bernstein H.B., Plasterer M.C., SchiffS.E., Kitchen C.M., Kitchen S., Zack J.A. CD4 expression on activated NK cells: ligation of CD4 induces cytokine expression and cell migration. J Immunol 2006, 177:3669-3676.
11. Biswas P., Mantelli B., Sica A., Malnati M., Panzeri C., Saccani A., Hasson H., Vecchi A., Saniabadi A., Lusso P., Lazzarin A., Beretta A. Expression of CD4 on human peripheral blood neutrophils. Blood 2003, 101:4452-4456.
12. Bluman E.M., Bartynski K.J., Avalos B.R., Caligiuri M.A. Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines. J Clin Invest 1996, 97:2722-2727.
13. Bonaparte M.I., Barker E. Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes. AIDS 2003, 17:487-494.
14. Bonaparte M.I., Barker E. Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules. Blood 2004, 104:2087-2094.
15. Boulet S., SharafiS., Simic N., Bruneau J., Routy J.P., Tsoukas C.M., Bernard N.F. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. AIDS 2008, 22:595-599.
16. Brenner B.G., Gryllis C., Wainberg M.A. Role of antibody-dependent cellular cytotoxicity and lymphokine-activated killer cells in AIDS and related diseases. J Leukoc Biol 1991, 50:628-640.
17. Caligiuri M.A. Human natural killer cells. Blood 2008, 112:461-469.
18. Caligiuri M.A., Zmuidzinas A., Manley T.J., Levine H., Smith K.A., Ritz J. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J Exp Med 1990, 171:1509-1526.
19. Carrington M., O'Brien S.J. The influence of HLA genotype on AIDS. Annu Rev Med 2003, 54:535-551.
20. Cerwenka A., Lanier L.L. Natural killer cells, viruses and cancer. Nat Rev Immunol 2001, 1:41-49.
21. Chehimi J., Azzoni L., Farabaugh M., Creer S.A., Tomescu C., Hancock A., Mackiewicz A., D'Alessandro L., Ghanekar S., Foulkes A.S., Mounzer K., Kostman J., Montaner L.J. Baseline viral load and immune activation determine the extent of reconstitution of innate immune effectors in HIV-1-infected subjects undergoing antiretroviral treatment. J Immunol 2007, 179:2642-2650.
22. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P.D., Wu L., Mackay C.R., LaRosa G., Newman W., Gerard N., Gerard C., Sodroski J. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996, 85:1135-1148.
23. Chun T.W., Carruth L., Finzi D., Shen X., DiGiuseppe J.A., Taylor H., Hermankova M., Chadwick K., Margolick J., Quinn T.C., Kuo Y.H., Brookmeyer R., Zeiger M.A., Barditch-Crovo P., Siliciano R.F. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997, 387:183-188.
24. Chung A.W., Rollman E., Center R.J., Kent S.J., Stratov I. Rapid degranulation of NK cells following activation by HIV-specific antibodies. J Immunol 2009, 182:1202-1210.
25. Cocchi F., DeVico A.L., Garzino-Demo A., Arya S.K., Gallo R.C., Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995, 270:1811-1815.
26. Cohen G.B., Gandhi R.T., Davis D.M., Mandelboim O., Chen B.K., Strominger J.L., Baltimore D. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999, 10:661-671.
27. Cooper M.A., Fehniger T.A., Caligiuri M.A. The biology of human natural killer-cell subsets. Trends Immunol 2001, 22:633-640.
28. Cooper M.A., Fehniger T.A., Fuchs A., Colonna M., Caligiuri M.A. NK cell and DC interactions. Trends Immunol 2004, 25:47-52.
29. De Maria A., Fogli M., Costa P., Murdaca G., Puppo F., Mavilio D., Moretta A., Moretta L. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur J Immunol 2003, 33:2410-2418.
30. Degli-Esposti M.A., Smyth M.J. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 2005, 5:112-124.
31. Devito C., Broliden K., Kaul R., Svensson L., Johansen K., Kiama P., Kimani J., Lopalco L., Piconi S., Bwayo J.J., Plummer F., Clerici M., Hinkula J. Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J Immunol 2000, 165:5170-5176.
32. Donaghy H., Gazzard B., Gotch F., Patterson S. Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood 2003, 101:4505-4511.
33. Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K.A., Cayanan C., Maddon P.J., Koup R.A., Moore J.P., Paxton W.A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667-673.
34. Fantuzzi L., Purificato C., Donato K., Belardelli F., Gessani S. Human immunodeficiency virus type 1 gp120 induces abnormal maturation and functional alterations of dendritic cells: a novel mechanism for AIDS pathogenesis. J Virol 2004, 78:9763-9772.
35. Fauci A.S., Mavilio D., Kottilil S. NK cells in HIV infection: paradigm for protection or targets for ambush. Nat Rev Immunol 2005, 5:835-843.
36. Fehniger T.A., Herbein G., Yu H., Para M.I., Bernstein Z.P., O'Brien W.A., Caligiuri M.A. Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection. J Immunol 1998, 161:6433-6438.
37. Ferbas J., Navratil J., Logar A., Rinaldo C. Selective decrease in HIV-1-induced alpha interferon production by peripheral blood mononuclear cells during HIV-1 infection. Clin Diagn Lab Immunol 1995, 2:138-142.
38. Ferlazzo G., Pack M., Thomas D., Paludan C., Schmid D., Strowig T., Bougras G., Muller W.A., Moretta L., Munz C. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci U S A 2004, 101:16606-16611.
39. Flamand L., Crowley R.W., Lusso P., Colombini-Hatch S., Margolis D.M., Gallo R.C. Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis. Proc Natl Acad Sci U S A 1998, 95:3111-3116.
40. Fogli M., Costa P., Murdaca G., Setti M., Mingari M.C., Moretta L., Moretta A., De Maria A. Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients. Eur J Immunol 2004, 34:2313-2321.
41. Fogli M., Mavilio D., Brunetta E., Varchetta S., Ata K., Roby G., Kovacs C., Follmann D., Pende D., Ward J., Barker E., Marcenaro E., Moretta A., Fauci A.S. Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. PLoS Pathog 2008, 4:e1000101.
42. Gao X., Nelson G.W., Karacki P., Martin M.P., Phair J., Kaslow R., Goedert J.J., Buchbinder S., Hoots K., Vlahov D., O'Brien S.J., Carrington M. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 2001, 344:1668-1675.
43. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G., Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002, 195:327-333.
44. Grassi F.R., Hosmalin A., McIlroy D., Calvez V., Debré P., Autran B. CD11c-positive dendritic cells are depleted in the blood of HIV-infected patients. AIDS 1999, 13:759-766.
45. Harada H., Goto Y., Ohno T., Suzu S., Okada S. Proliferative activation up-regulates expression of CD4 and HIV-1 co-receptors on NK cells and induces their infection with HIV-1. Eur J Immunol 2007, 37:2148-2155.
46. Hirbod T., Broliden K. Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women. J Intern Med 2007, 262:44-58.
47. Hosmalin A., Lebon P. Type I IFN interferon production in HIV-infected patients. J Leukoc Biol 2006, 80:984-993.
48. Hu P.F., Hultin L.E., Hultin P., Hausner M.A., Hirji K., Jewett A., Bonavida B., Detels R., Giorgi J.V. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56-cells with low lytic activity. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 10:331-340.
49. Jennes W., Verheyden S., Demanet C., Adje-Toure C.A., Vuylsteke B., Nkengasong J.N., Kestens L. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J Immunol 2006, 177:6588-6592.
50. Karre K., Ljunggren H.G., Piontek G., Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986, 319:675-678.
51. Kaslow R.A., Carrington M., Apple R., Park L., Munoz A., Saah A.J., Goedert J.J., Winkler C., O'Brien S.J., Rinaldo C., Detels R., Blattner W., Phair J., Erlich H., Mann D.L. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996, 2:405-411.
52. Kitchen S.G., Korin Y.D., Roth M.D., Landay A., Zack J.A. Costimulation of naive CD8(+) lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infection. J Virol 1998, 72:9054-9060.
53. Kottilil S., Chun T.W., Moir S., Liu S., McLaughlin M., Hallahan C.W., Maldarelli F., Corey L., Fauci A.S. Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. J Infect Dis 2003, 187:1038-1045.
54. Kottilil S., Shin K., Jackson J.O., Reitano K.N., O'Shea M A., Yang J., Hallahan C.W., Lempicki R., Arthos J., Fauci A.S. Innate immune dysfunction in HIV infection: effect of HIV envelope-NK cell interactions. J Immunol 2006, 176:1107-1114.
55. Kottilil S., Shin K., Planta M., McLaughlin M., Hallahan C.W., Ghany M., Chun T.W., Sneller M.C., Fauci A.S. Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia. J Infect Dis 2004, 189:1193-1198.
56. Lanier L.L. NK cell recognition. Annu Rev Immunol 2005, 23:225-274.
57. Lichtner M., Rossi R., Rizza M.C., Mengoni F., Sauzullo I., Massetti A.P., Luzi G., Hosmalin A., Mastroianni C.M., Vullo V. Plasmacytoid dendritic cells count in antiretroviral-treated patients is predictive of HIV load control independent of CD4+ T-cell count. Curr HIV Res 2008, 6:19-27.
58. Liu R., Paxton W.A., Choe S., Ceradini D., Martin S.R., Horuk R., MacDonald M.E., Stuhlmann H., Koup R.A., Landau N.R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996, 86:367-377.
59. Long E.O. Versatile signaling through NKG2D. Nat Immunol 2002, 3:1119-1120.
60. Loubeau M., Ahmad A., Toma E., Menezes J. Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 16:137-145.
61. Lucia B., Jennings C., Cauda R., Ortona L., Landay A.L. Evidence of a selective depletion of a CD16+ CD56+ CD8+ natural killer cell subset during HIV infection. Cytometry 1995, 22:10-15.
62. Lum J.J., Schnepple D.J., Nie Z., Sanchez-Dardon J., Mbisa G.L., Mihowich J., Hawley N., Narayan S., Kim J.E., Lynch D.H., Badley A.D. Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity. J Virol 2004, 78:6033-6042.
63. Lusso P., Garzino-Demo A., Crowley R.W., Malnati M.S. Infection of gamma/delta T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection. J Exp Med 1995, 181:1303-1310.
64. Martin M.P., Dean M., Smith M.W., Winkler C., Gerrard B., Michael N.L., Lee B., Doms R.W., Margolick J., Buchbinder S., Goedert J.J., O'Brien T.R., Hilgartner M.W., Vlahov D., O'Brien S.J., Carrington M. Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 1998, 282:1907-1911.
65. Martin M.P., Gao X., Lee J.H., Nelson G.W., Detels R., Goedert J.J., Buchbinder S., Hoots K., Vlahov D., Trowsdale J., Wilson M., O'Brien S.J., Carrington M. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002, 31:429-434.
66. Mastroianni C.M., d'Ettorre G., Forcina G., Vullo V. Teaching tired T cells to fight HIV: time to test IL-15 for immunotherapy?. Trends Immunol 2004, 25:121-125.
67. Mavilio D., Benjamin J., Daucher M., Lombardo G., Kottilil S., Planta M.A., Marcenaro E., Bottino C., Moretta L., Moretta A., Fauci A.S. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc Natl Acad Sci U S A 2003, 100:15011-15016.
68. Mavilio D., Benjamin J., Kim D., Lombardo G., Daucher M., Kinter A., Nies-Kraske E., Marcenaro E., Moretta A., Fauci A.S. Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys. Blood 2005, 106:1718-1725.
69. Mavilio, D., Lombardo, G., Benjamin, J., Kim, D., Follman, D., Marcenaro, E., O'Shea, M.A., Kinter, A., Kovacs, C., Moretta, A. and Fauci, A.S. (2005b). Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci U S A 25.
70. Mavilio D., Lombardo G., Kinter A., Fogli M., La Sala A., Ortolano S., Farschi A., Follmann D., Gregg R., Kovacs C., Marcenaro E., Pende D., Moretta A., Fauci A.S. Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J Exp Med 2006, 203:2339-2350.
71. Montoya C.J., Velilla P.A., Chougnet C., Landay A.L., Rugeles M.T. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals. Clin Immunol 2006, 120:138-146.
72. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002, 2:957-964.
73. Moretta A., Bottino C., Vitale M., Pende D., Biassoni R., Mingari M.C., Moretta L. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 1996, 14:619-648.
74. Moretta A., Bottino C., Vitale M., Pende D., Cantoni C., Mingari M.C., Biassoni R., Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001, 19:197-223.
75. Moretta A., Bottino C., Mingari M.C., Biassoni R., Moretta L. What is a natural killer cell?. Nat Immunol 2002, 3:6-8.
76. Motsinger A., Haas D.W., Stanic A.K., Van Kaer L., Joyce S., Unutmaz D. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J Exp Med 2002, 195:869-879.
77. Nagler A., Lanier L.L., Cwirla S., Phillips J.H. Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 1989, 143:3183-3191.
78. Noraz N., Verrier B., Fraisier C., Desgranges C. Cell surface phenotypic changes induced in H9 T cells chronically infected with HTLV type I or HIV type 1 or coinfected with the two viruses. AIDS Res Hum Retroviruses 1995, 11:145-154.
79. Oliva A., Kinter A.L., Vaccarezza M., Rubbert A., Catanzaro A., Moir S., Monaco J., Ehler L., Mizell S., Jackson R., Li Y., Romano J.W., Fauci A.S. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J Clin Invest 1998, 102:223-231.
80. Parato K.G., Kumar A., Badley A.D., Sanchez-Dardon J.L., Chambers K.A., Young C.D., Lim W.T., Kravcik S., Cameron D.W., Angel J.B. Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10. AIDS 2002, 16:1251-1256.
81. Patterson S., Knight S.C. Susceptibility of human peripheral blood dendritic cells to infection by human immunodeficiency virus. J Gen Virol 1987, 68(Pt4):1177-1181.
82. Pierson T., McArthur J., Siliciano R.F. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol 2000, 18:665-708.
83. Raulet D.H. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 2004, 5:996-1002.
84. Ravet S., Scott-Algara D., Bonnet E., Tran H.K., Tran T., Nguyen N., Truong L.X., Theodorou I., Barre-Sinoussi F., Pancino G., Paul P. Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals. Blood 2007, 109:4296-4305.
85. Rinaldo C.R., Piazza P. Virus infection of dendritic cells: portal for host invasion and host defense. Trends Microbiol 2004, 12:337-345.
86. Saidi H., Melki M.T., Gougeon M.L. HMGB1-dependent triggering of HIV-1 replication and persistence in dendritic cells as a consequence of NK-DC cross-talk. PLoS ONE 2008, 3:e3601.
87. Schenal M., Lo Caputo S., Fasano F., Vichi F., Saresella M., Pierotti P., Villa M.L., Mazzotta F., Trabattoni D., Clerici M. Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients. AIDS 2005, 19:653-661.
88. Scott-Algara D., Paul P. NK cells and HIV infection: lessons from other viruses. Curr Mol Med 2002, 2:757-768.
89. Scott-Algara D., Truong L.X., Versmisse P., David A., Luong T.T., Nguyen N.V., Theodorou I., Barre-Sinoussi F., Pancino G. Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J Immunol 2003, 171:5663-5667.
90. Scott-Algara D., Arnold V., Didier C., Kattan T., Pirozzi G., Barre-Sinoussi F., Pancino G. The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cells. PLoS ONE 2008, 3:e1975.
91. Siegal F.P., Lopez C., Fitzgerald P.A., Shah K., Baron P., Leiderman I.Z., Imperato D., Landesman S. Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity. J Clin Invest 1986, 78:115-123.
92. Sirianni M.C., Ensoli F., Alario C., Fiorelli V., Sacco G., Topino S., Iebba F., Mezzaroma I., Aiuti F. Distribution of the natural killer-related receptor for HLA-C during highly active antiretroviral therapy for human immunodeficiency virus infection. Hum Immunol 2001, 62:1328-1334.
93. Smed-Sorensen A., Lore K., Walther-Jallow L., Andersson J., Spetz A.L. HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation. Blood 2004, 104:2810-2817.
94. Smith M.W., Dean M., Carrington M., Huttley G.A., O'Brien S.J. CCR5-delta 32 gene deletion in HIV-1 infected patients. Lancet 1997, 350:741. author reply 742.
95. Smyth M.J., Godfrey D.I., Trapani J.A. A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 2001, 2:293-299.
96. Soumelis V., Scott I., Gheyas F., Bouhour D., Cozon G., Cotte L., Huang L., Levy J.A., Liu Y.J. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 2001, 98:906-912.
97. Steinman R.M., Nussenzweig M.C. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A 2002, 99:351-358.
98. Tarazona R., Casado J.G., Delarosa O., Torre-Cisneros J., Villanueva J.L., Sanchez B., Galiani M.D., Gonzalez R., Solana R., Pena J. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals. J Clin Immunol 2002, 22:176-183.
99. Tasca S., Tambussi G., Nozza S., Capiluppi B., Zocchi M.R., Soldini L., Veglia F., Poli G., Lazzarin A., Fortis C. Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis. AIDS 2003, 17:2291-2298.
100. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989, 47:187-376.
101. Ullum H., Gotzsche P.C., Victor J., Dickmeiss E., Skinhoj P., Pedersen B.K. Defective natural immunity: an early manifestation of human immunodeficiency virus infection. J Exp Med 1995, 182:789-799.
102. Ullum H., Cozzi Lepri A., Aladdin H., Katzenstein T., Victor J., Phillips A.N., Gerstoft J., Skinhoj P., Klarlund Pedersen B. Natural immunity and HIV disease progression. AIDS 1999, 13:557-563.
103. Valentin A., Rosati M., Patenaude D.J., Hatzakis A., Kostrikis L.G., Lazanas M., Wyvill K.M., Yarchoan R., Pavlakis G.N. Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy. Proc Natl Acad Sci U S A 2002, 99:7015-7020.
104. Vieillard V., Strominger J.L., Debre P. NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand. Proc Natl Acad Sci U S A 2005, 102:10981-10986.
105. Vieillard V., Habib R.E., Brochard P., Delache B., Bovendo H.F., Calvo J., Morin J., Picq I., Martinon F., Vaslin B., Le Grand R., Debre P. CCR5 or CXCR4 use influences the relationship between CD4 cell depletion, NKp44L expression and NK cytotoxicity in SHIV-infected macaques. AIDS 2008, 22:185-192.
106. Vieillard V., Le Grand R., Dausset J., Debre P. A vaccine strategy against AIDS: an HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaques. Proc Natl Acad Sci U S A 2008, 105:2100-2104.
107. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat Immunol 2008, 9:503-510.
108. Walzer, T., Dalod, M., Robbins, S.H., Zitvogel, L. and Vivier, E. (2005). Natural killer cells and dendritic cells: "l'union fait la force". Blood.
109. Ward J., Bonaparte M., Sacks J., Guterman J., Fogli M., Mavilio D., Barker E. HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts. Blood 2007, 110:1207-1214.
110. Wilflingseder D., Mullauer B., Schramek H., Banki Z., Pruenster M., Dierich M.P., Stoiber H. HIV-1-induced migration of monocyte-derived dendritic cells is associated with differential activation of MAPK pathways. J Immunol 2004, 173:7497-7505.
111. Yang L.P., Riley J.L., Carroll R.G., June C.H., Hoxie J., Patterson B.K., Ohshima Y., Hodes R.J., Delespesse G. Productive infection of neonatal CD8+ T lymphocytes by HIV-1. J Exp Med 1998, 187:1139-1144.
112. Zitvogel L. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med 2002, 195:F9-F14.